Flora E. van Leeuwen, PhD, of the Netherlands Cancer Institute, discusses cardiovascular disease risk after treatment-induced primary ovarian insufficiency in female survivors of Hodgkin lymphoma (Abstract 114).
David Baraghoshi, of the Huntsman Cancer Institute at the University of Utah, discusses an assessment of cardiovascular risk more than 10 years after diagnosis for colorectal cancer survivors compared with a cancer-free general population cohort (Abstract 113).
Christopher J. Recklitis, PhD, MPH, of Dana-Farber Cancer Institute, summarizes two key papers on mental health: suicide risk among survivors of head and neck cancer vs other types of cancer; and the fear of cancer recurrence—its associations with mental health status and individual characteristics among cancer survivors (Abstract 146).
Paul B. Jacobsen, PhD, of the National Cancer Institute, discusses his evaluation of whether survivorship care plans have a positive impact on health outcomes and health-care delivery for cancer survivors, in both the long and short term (Abstract 2).
Lawrence N. Shulman, MD, of Abramson Cancer Center at the University of Pennsylvania, discusses the Commission on Cancer’s efforts to promote robust survivorship care and how its new recommendations will affect clinical practice and patients.
Lynda M. Beaupin, MD, of the Roswell Park Cancer Institute, discusses her findings on the factors contributing to adolescent and young adult cancer survivors not seeking follow-up care (Abstract 29).
